Metabolic Heterogeneity in Liver Cancer with Portal Vein Thrombus
Author Information
Author(s): Zhang Xiu‐Ping, Zou Wen‐Bo, Li Zhen‐Qi, Yu Ze‐Tao, Yu Shao‐Bo, Lin Zhao‐Yi, Wu Fei‐Fan, Liu Peng‐Jiong, Hu Ming‐Gen, Liu Rong, Gao Yu‐Zhen
Primary Institution: The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital
Hypothesis
This study aims to analyze the metabolic heterogeneity of hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) using multi-omics approaches.
Conclusion
The study reveals significant metabolic heterogeneity in non-malignant cells within the tumor microenvironment of HCC and PVTT, which may guide prognosis and treatment strategies.
Supporting Evidence
- Patients with a higher combined index had a relatively poor prognosis.
- Metabolism of polyamines was identified as a key pathway in HCC and PVTT.
- ODC1 expression was significantly higher in PVTT compared to normal tissue.
Takeaway
Researchers looked at how cancer cells in the liver use food differently, especially when there's a blockage in the blood vessels, to help doctors understand how to treat it better.
Methodology
The study used single-cell RNA sequencing and multi-omics data analysis to explore metabolic pathways in HCC and PVTT.
Potential Biases
Potential selection bias due to reliance on public datasets.
Limitations
The study relies on public datasets, which may introduce selection bias, and lacks research on the impact of metabolites on PVTT.
Participant Demographics
Patients included 10 with primary HCC, 2 with PVTT, and 8 with adjacent normal liver tissues.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI = 0.580–0.864
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website